TP53 and breast cancer: Treatment with linoelaidic acid at the dose of 5 μM/ml, led to the overexpression of p53 protein and anti-inflammatory cytokines (IL-1ra and IL-10) on MCF-7 cells compared to untreated breast cancer cells.